0001209191-19-061108.txt : 20191218
0001209191-19-061108.hdr.sgml : 20191218
20191218161926
ACCESSION NUMBER: 0001209191-19-061108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191216
FILED AS OF DATE: 20191218
DATE AS OF CHANGE: 20191218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WU JINN
CENTRAL INDEX KEY: 0001314254
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 191292710
MAIL ADDRESS:
STREET 1: 107 MORGAN LANE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-16
0
0001300699
Athenex, Inc.
ATNX
0001314254
WU JINN
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
1
0
0
0
Common Stock
2019-12-16
4
M
0
30000
4.55
A
351208
D
Stock Option (Right to Buy)
4.55
2019-12-16
4
M
0
30000
0.00
A
2013-01-02
2023-01-02
Common Stock
30000
60000
D
Stock Option (Right to Buy)
4.55
2014-02-12
2024-02-12
Common Stock
10000
10000
D
Stock Option (Right to Buy)
5.50
2015-02-05
2025-02-05
Common Stock
54000
54000
D
Stock Option (Right to Buy)
5.50
2017-03-20
2025-03-20
Common Stock
96000
96000
D
Stock Option (Right to Buy)
11.00
2027-06-13
Common Stock
28500
28500
D
Stock Option (Right to Buy)
17.30
2028-03-27
Common Stock
16500
16500
D
Stock Option (Right to Buy)
13.17
2029-02-28
Common Stock
15000
15000
D
The option vests in four equal annual installments beginning on June 13, 2018.
This option vests in four equal annual installments beginning on March 27, 2019.
The option vests in four equal annual installments beginning on February 28, 2020.
/s/ Teresa Bair, Attorney-in-Fact
2019-12-18